medigraphic.com
ISSN 0016-3813 (Print)

2001, Number 6

<< Back Next >>

Gac Med Mex 2001; 137 (6)

Apoptosis and Its Biomedical Importance.

Ortega-Camarillo C, Díaz-Flores M, Avalos-Rodríguez A, Vergara-Onofre M, Rosales-Torres AM

Language: Spanish
References: 84
Page: 563-577
PDF size: 157.14 Kb.


ABSTRACT

Cell death can occur through apoptotic or necrotic death pathways. Membrane disruption leads to inflammation, a typical feature of necrosis. Apoptosis constitutes a genetically controlled physiologic process of cell removal. It is characterized by cell shrinkage, chromatin condensation, and DNA cleavage. Apoptotic cells are rapidly recognized and engulfed by phagocytes thus inhibiting an inflammatory response following necrosis. Apoptosis has been proposed as a basic event to protect tissue homeostasis. This paper analyzes the genetic, biochemical, and morphologic characteristics related to apoptosis, as well as its relationship to certain illnesses.


REFERENCES

  1. 1. Samali A, Gorman AM, Cotter TG. Apoptosis the story so far. Experientia 1996;52:933-941.

  2. 2. Arends JM, Morris GR, Wyllie AH. The role of the endonuclease. Am J Pathol 1990;136:593-608.

  3. 3. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.

  4. 4. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;144:67-77.

  5. 5. Penninger MJ, Kroemer G. Molecular and cellular mechanisms of T lymphocyte apoptosis. Adv Immunol 1998;68: 51-144.

  6. 6. Vaux DL. Toward understanding of the molecular mechanism of physiological cell death. Proc Natl Acad Sci USA 1993;90:786-789.

  7. 7. Wyllie AH. Apoptosis: an overview. Br Med Bull 1997;53:451-465.

  8. 8. Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J Immunol 1994;153:3218-3227.

  9. 9. Keiss W, Gallaher B. Hormonal control of programmed cell death/apoptosis. Eur J Endocrinol 1988;138:482-491.

  10. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993;341:12511254

  11. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-556.

  12. Cohen GM, Sun Xiao-Ming, Snowden RT, Dinsdale D, Skilleter N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 1992;286:331-334.

  13. Savill J. Apoptosis in disease. Eur J Clin Invest 1994;24:715-723.

  14. Thatte U, Dahanukar S. Apoptosis: clinical relevance and pharmacological manipulation. Drugs 1997;54:511-532.

  15. Schwartzman AR, Cidlowski AJ. Apoptosis: the biochemistry and biology of programmed cell death. Endocrine Rev 1993;14:133-151.

  16. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1302-1308.

  17. Merino JJ, Cordero-Campaña MI. Bases moleculares del proceso de muerte celular programada: implicaciones de la proteína p53 y otras proteínas en el control del ciclo celular. Mecanismos de acción. Revisión. Invest Clin 1998;39:323-358.

  18. Wong GHW, Gaddel D. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 1994;152:1751-1755.

  19. Wissin D, Mouritzen H, Jäättela M. TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20. Free Radic Biol Med 1998;25:57-65.

  20. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-400.

  21. Osborne AB, Schwartz ML. Essential genes that regulate apoptosis. Trends Cell Biol 1994;4:394-22.

  22. Hetts WS. To die or not to die. An overview of apoptosis and its role in disease. JAMA 1998;279:300-307.

  23. Cohen MG. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16.

  24. Gorman MA Orrenius S, Ceccatelli S. Apoptosis in neuronal cells: role of caspases. Neuror Report 1998;9:R49-R55.

  25. Thornberry AN, Lazebnik Y. Caspases: Enemies within. Science 1998;281:1312-1316.

  26. Allsopp TE, Wyatt S, Peterson HF, Davies AM. The protooncogene bcl-2 can selectively rescue neutrophic factor-dependent neurons from apoptosis. Cell 1993;73: 295-307.

  27. Adams MJ, Cory S. The bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1325.

  28. Green RD, Reed CJ. Mitochondria and apoptosis. Science 1998;281:13091312.

  29. Jacobson MD, Burne JF, King MP, Migashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993. p. 361-368.

  30. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.

  31. Evan GI, Wyllie AH, Gilbert CS. Induction of apoptosis in fibroblasts by c-myc protein: Cell 1992;69:119-128,399.

  32. Nuñez G, Clarke FM. The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 1994;4:399-403.

  33. Ryan JJ, Prochownick E, Gottlied C , Apel IJ, Merino R, Nuñez G, et al. C-myc and Bcl-2 modulan p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994;91:58785882.

  34. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lissa F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem 1999;264:687-701.

  35. Martin SJ, Reutelingsperger PMC, McGahon JA, Rader AJ, Van-Schie AAC, LaFace MD, Green RD. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of initiating Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-1556.

  36. McGahon AJ, Cotter TG, Green DR. The Abl oncogene family and apoptosis. Cell Death Diff 1994;1:77-83.

  37. Flora PK, Gregory CD. Recognition of apoptotic cells by human macrophages: inhibition by a monocyte/macrophages-specific monoclonal antibody. Eur J Immunol 1994;24:2625-2632.

  38. Higuchi Y, Matsukawa S. Glutathione depletion induces giant DNA and High-molecular-weight DNA fragmentation associate with apoptosis through lipid peroxidation and protein kinase activation in C6 glioma cells. Arch Biochem Biophys 1999;363:33-42.

  39. Lennon SV, Martin SJ, Cotter TG. Dose dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif 1991;24:203-214.

  40. Shimizu S, Narita M, Tsujimoto Y. Bcl-family proteins regulate the release of apoptogenic cytocrome C by the mitochondrial channel VDAC. Lett Nature 1999;399:483-487.

  41. Zhong LT, Sarafian T, Kane DF, Charles AC, Mah SP, Edwards RH, Bredesen DE. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993; 90:4533-4537.

  42. Larrick JW, Wright SC. Citotoxic mechanism of tumor necrosis factor a. FASEB J 1990;4:3215-3223.

  43. Hockenbery DM, Oltavai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.

  44. Sandstrom PA, Tebbey PW, Van Cleave S, Buttke TM. Lipid hydrogen peroxides induce apoptosis in T cells displaying and HIV-associated glutathione peroxidases deficiency. J Biol Biochem 1994;269:798-801.

  45. Clutton S. The importance of oxidative stress in apoptosis. Br Med Bull 1997;53:662-668.

  46. Wolfe JT, Ross D, Cohen GM. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Letter 1994;352:58-62.

  47. Tomei LD, Shapiro JP, Cope FO. Apoptosis in C3H/I0t1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 1993; 90:853-857.

  48. Koremeyer SJ, Yin XM, Oltavai ZN, Veis-Novack DJ, Linnete GP. Reactive oxygen species and regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta 1995;127:63-66.

  49. Oberhammer AF, Hochegger K, Fröschi G, Tienfenbacher R, Pavelka M. Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J Cell Biol 1994;126:827-837.

  50. Walker PR, Kokileva L, LeBlanc J, Sikorska M. Dectetion of the initial stages of DNA fragmentation in apoptosis. BioTechniques 1993;15:10321040

  51. Lazebnik AY, Cole S, Cooke CA, Nelson GW, Earnshaw CW. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J Cell Biol 1993;123:7-22.

  52. Cohen JJ. Programmed cell death in the immune system. Adv Immunol 1991;50:55-83.

  53. Shiratsuchi A, Osada S, Kanazawa S, Nakanishi Y. Essential role phosphatidylserine externalization in apoptosing cell phagocytosis by macrophages. Biochem Biophys Res Commun 1998;246:549-555.

  54. Orrenius S, McConkey DJ, Bellomo G, Nicotera P. Role of Ca+2 in toxic cell killing. Trends Pharmacol Sci, 1989;10:281-285.

  55. Knight CRL, Rees RC, Griffín M. Apoptosis: a potential role for cytosolic transgluminase and its importance in tumor progression. Biochem Biophys Acta 1991;1096: 312-318.

  56. Squier MKT, Miller HJJ. Calpain activation in apoptosis. J Cell Physiol 1994;159:229-237.

  57. Rathmell CJ, Thompson BC. The central effectors of cell death in the immune system. Ann Rev Immunol 1999;17:781-828.

  58. Earnshaw CW, Martins ML, Kaufmann HS. Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem 1999;68:383-424.

  59. Duan HJ, Chinnaiya AM, Hudson PL, Wing JP, He WW, Dixit VM. ICE-LAP3 a novel mammalian homologue of the Caenorhabditis elegans cell death protein. Ced-3 is activated during FAS and tumor necrosis factor induced apoptosis. J Biol Chem 1996;271:1621-1625.

  60. Singer II, Scotts S, Chin J, Baney EK, limjuko G, Miller DK, Chapman K, Kostura MJ. The interleukina 1-b-converting enzyme (ICE) is localized on the external cell surface membrans and the cytoplasm ground substance of human monocytes by immuno-electron microscopy. J Exp Med 1995;182:1447-1459.

  61. Leist M, Single B, Castoldi FA, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 1997;185:1481-1486.

  62. Savill JS, Henson PM, Haslett C. Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge-sensitive" recognition mechanism. J Clin Invest 1989; 84:1518-1527.

  63. Savill JS, Fadok V, Henson P, Haslett C. Phagocyte recognition of cell undergoing apoptosis. Immunol Today 1993;14:131-136.

  64. Fadok VA, Savill 1 JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992;149:4029-4035.

  65. Fadok VA, Laszlo DJ, Noble PW, Weinstein DWH, Riches, Henson PM. Particle digestibility is required for induction of phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cell. J Immunol 1993;151:4274-428 5.

  66. 66 Prahan D, Krahling S, Williamson P, Schleger RA. Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell 1997;8:767-778.

  67. Pytela R, Pierschbaccher MD, Ruoslahti E. A 125/115 kDa cell surface receptor specific for vitronectin interacts with the Arg-Gly-Asp adhesion sequence derived from fibronectin. Proc. Natl. Acad. Sci. USA 1985;82:5766.

  68. Morris EG, Morris RG, Hargreaves AD, Duval E, Wyllie AH. Hormoneinduced death. 11. Surface changes in thymocytes undergoing apoptosis. Am J Pathol 1984;115: 426-431.

  69. Savill JS, Hogg N, Ran Y, Haslett C. Thrombospondin cooperate with CD36 and vibronnectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992;90:1513-1529.

  70. Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblast with participation of fibroblast vibronnectin receptor and involvement of a mannose/fucose specific lectin. J Immunol 1994;153:3218-3227.

  71. Arends JM, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991;32:223-254.

  72. Young SL, Dawson WC, Eliopoulos GA. Virus and apoptosis. Br Med Bull 1997;53:509-521.

  73. Fadeel B, Orrenius S, Zhivitovsk B. Apoptosis in human disease: A new skin for the old ceremony? Biochem Biophys Res Commun 1999;266:699-714.

  74. Strasser A, Vaux DL. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 1996;93:2239-2244.

  75. Benítez-Bribiesca L. Assessment of apoptosis in tumor growth: importance in clinical oncology and cancer therapy. En: When Cells Die. Lockshin AR, Zakeri Z and Tilly LJ (Eds.) Wiley-Liss Publication. Edition New York, 1998. p. 453-482.

  76. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in human leukemia cell line. Blood 1993;81:151-157.

  77. López-Hoyos M, Carrió R, Merino J, Merino R. Regulación de la apoptosis en linfocitos B y T por los genes Bcl-2 y Bcl-x. Rev Esp Reumatol 1998;25:63-73.

  78. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.

  79. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.

  80. Donehower LA, Harvey M, Slagle BL, McArther MJ, Montgomery CA Jr, Butel JS, Bradley A. Mice deficient for p53 are developmently normal but susceptible to spontaneous tumors. Nature 1992;356:215-221.

  81. Finkel HT, Casella RC. AIDS and cell death en When Cells Die. En: When Cells Die. Lockshin AR, Zakeri Z and Tilly LJ (Eds.) Wiley-Liss Publication. Edition New York 1998. p. 289-318.

  82. Orrenius S. Apoptosis: molecular mechanism and implications for human disease. J Int Med 1995;237:529-536.

  83. Tapia R, Pasantes H, Massieu L, Arias C. Mecanismos celulares y moleculares de la neurodegeneración. Gac Med Mex 1998;134:685-703.

  84. Cotman WC, Cribbs HD, Pike JC, Ivins JK. Cell death in Alzheimer's disease en When Cells Die. En: When Cells Die. Lockshin AR, Zakeri Z and Tilly LJ (Eds.) Wiley-Liss Publication. Edición New York 1998. p. 385-409.




2020     |     www.medigraphic.com